ABG 30 (Morphine sulphate extended-release 30 mg)
Pill imprint ABG 30 has been identified as Morphine sulphate extended-release 30 mg.
Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Images for ABG 30 (Morphine sulphate extended-release 30 mg)
- 30 mg
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00591-3741||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
|66336-0173||Dispensing Solutions Inc. (repackager)|
|49999-0846||Lake Erie Medical and Surgical Supply (repackager)|
|55887-0092||Diversified Healthcare Services Inc (repackager)|
|10544-0379||Blenheim Pharmacal Inc (repackager)|
|16590-0607||Stat RX USA LLC (repackager)|
|54868-4033||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about morphine
- Morphine concentrate
- Morphine extended-release capsules
- Morphine immediate-release
- Morphine immediate-release tablets
- More (7) »